Association Between SPARC Polymorphisms and Ankylosing Spondylitis and Its mRNA and Protein Expression in a Chinese Han Population: A Case–Control Study

References

• Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007;369:1379–1390. doi:10.1016/S0140-6736(07)60635-7
   PubMed Web of Science ®Google Scholar
• Chatzikyriakidou A, Georgiou I, Voulgari PV, Drosos AA. The role of tumor necrosis factor (TNF)-alpha and TNF receptor polymorphisms in susceptibility to ankylosing spondylitis. Clin Exp Rheumatol. 2009;27:645–648.
   PubMed Web of Science ®Google Scholar
• Ebrahimiadib N, Berijani S, Ghahari M, Pahlaviani FG. Ankylosing Spondylitis. J Ophthalmic Vis Res. 2021;16:462–469.
   PubMed Web of Science ®Google Scholar
• Brown MA, Wordsworth BP, Reveille JD. Genetics of ankylosing spondylitis. Clin Exp Rheumatol. 2002;20:S43–49.
   PubMed Web of Science ®Google Scholar
• Reveille JD. Genetics of spondyloarthritis--beyond the MHC. Nat Rev Rheumatol. 2012;8:296–304. doi:10.1038/nrrheum.2012.41
   PubMed Web of Science ®Google Scholar
• Maksymowych WP, Brown MA. Genetics of ankylosing spondylitis and rheumatoid arthritis: where are we at currently, and how do they compare?. Clin Exp Rheumatol. 2009;27:S20–25.
   PubMedGoogle Scholar
• Burton PR, Clayton DG, Cardon LR, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat.Genet. 2007;39:1329–1337.
   PubMed Web of Science ®Google Scholar
• Danoy P, Pryce K, Hadler J, et al. Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn’s disease. PLoS Genet. 2010;6:e1001195. doi:10.1371/journal.pgen.1001195
   PubMed Web of Science ®Google Scholar
• Gagliardi MC, Teloni R, Mariotti S, et al. Endogenous PGE2 promotes the induction of human Th17 responses by fungal ss-glucan. J Leukoc Biol. 2010;88:947–954. doi:10.1189/jlb.0310139
   PubMed Web of Science ®Google Scholar
• Evans DM, Spencer CC, Pointon JJ, et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet. 2011;43:761–767. doi:10.1038/ng.873
   PubMed Web of Science ®Google Scholar
• Pimentel-Santos FM, Ligeiro D, Matos M, et al. Association of IL23R and ERAP1 genes with ankylosing spondylitis in a Portuguese population. Clin Exp Rheumatol. 2009;27:800–806.
   PubMed Web of Science ®Google Scholar
• Magrey M, Khan MA. Osteoporosis in ankylosing spondylitis. Curr Rheumatol Rep. 2010;12:332–336. doi:10.1007/s11926-010-0122-1
   PubMedGoogle Scholar
• Davey-Ranasinghe N, Deodhar A. Osteoporosis and vertebral fractures in ankylosing spondylitis. Curr Opin Rheumatol. 2013;25:509–516. doi:10.1097/BOR.0b013e3283620777
   PubMed Web of Science ®Google Scholar
• Klingberg E, Lorentzon M, Mellstrom D, et al. Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment. Arthritis Res Ther. 2012;14:R108. doi:10.1186/ar3833
   PubMed Web of Science ®Google Scholar
• Neumann A, Haschka J, Kleyer A, et al. Cortical bone loss is an early feature of nonradiographic axial spondyloarthritis. Arthritis Res Ther. 2018;20:202. doi:10.1186/s13075-018-1620-1
   PubMed Web of Science ®Google Scholar
• Kilic E, Ozgocmen S. Bone mass in axial spondyloarthritis: a literature review. World J Orthop. 2015;6:298–310. doi:10.5312/wjo.v6.i2.298
   PubMedGoogle Scholar
• Akgol G, Kamanli A, Ozgocmen S. Evidence for inflammation-induced bone loss in non-radiographic axial spondyloarthritis. Rheumatology. 2014;53:497–501. doi:10.1093/rheumatology/ket385
   PubMed Web of Science ®Google Scholar
• Singh HJ, Nimarpreet K, Das S, Kumar A, Prakash S. Study of bone mineral density in patients with ankylosing spondylitis. J Clin Diagn Res. 2013;7:2832–2835. doi:10.7860/JCDR/2013/6779.3770
   PubMedGoogle Scholar
• Carter S, Lories RJ. Osteoporosis: a paradox in ankylosing spondylitis. Curr Osteoporos Rep. 2011;9:112–115. doi:10.1007/s11914-011-0058-z
   PubMedGoogle Scholar
• Lim MJ, Kang KY. A contemporary view of the diagnosis of osteoporosis in patients with axial spondyloarthritis. Front Med. 2020;7:569449. doi:10.3389/fmed.2020.569449
   Web of Science ®Google Scholar
• Thudium CS, Nielsen SH, Sardar S, et al. Bone phenotypes in rheumatology - there is more to bone than just bone. BMC Musculoskelet Disord. 2020;21:789. doi:10.1186/s12891-020-03804-2
   PubMed Web of Science ®Google Scholar
• Termine JD, Kleinman HK, Whitson SW, Conn KM, McGarvey ML, Martin GR. Osteonectin, a bone-specific protein linking mineral to collagen. Cell. 1981;26:99–105. doi:10.1016/0092-8674(81)90037-4
   PubMed Web of Science ®Google Scholar
• Bradshaw AD. Diverse biological functions of the SPARC family of proteins. Int J Biochem Cell Biol. 2012;44:480–488. doi:10.1016/j.biocel.2011.12.021
   PubMed Web of Science ®Google Scholar
• Peixoto E, Atorrasagasti C, Aquino JB, et al. SPARC (secreted protein acidic and rich in cysteine) knockdown protects mice from acute liver injury by reducing vascular endothelial cell damage. Gene Ther. 2015;22:9–19. doi:10.1038/gt.2014.102
   PubMed Web of Science ®Google Scholar
• Melouane A, Yoshioka M, Kanzaki M, St-Amand J. Sparc, an EPS-induced gene, modulates the extracellular matrix and mitochondrial function via ILK/AMPK pathways in C2C12 cells. Life Sci. 2019;229:277–287. doi:10.1016/j.lfs.2019.05.070
   PubMed Web of Science ®Google Scholar
• Sangaletti S, Gioiosa L, Guiducci C, et al. Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient mice. J Cell Sci. 2005;118:3685–3694. doi:10.1242/jcs.02474
   PubMed Web of Science ®Google Scholar
• Motamed K. SPARC (osteonectin/BM-40). Int J Biochem Cell Biol. 1999;31:1363–1366. doi:10.1016/S1357-2725(99)00090-4
   PubMed Web of Science ®Google Scholar
• Delany AM, Amling M, Priemel M, Howe C, Baron R, Canalis E. Osteopenia and decreased bone formation in osteonectin-deficient mice. J Clin Invest. 2000;105(7):915–923. doi:10.1172/JCI7039
   PubMed Web of Science ®Google Scholar
• Mansergh FC, Wells T, Elford C, et al. Osteopenia in Sparc (osteonectin)-deficient mice: characterization of phenotypic determinants of femoral strength and changes in gene expression. Physiol Genomics. 2007;32(1):64–73. doi:10.1152/physiolgenomics.00151.2007
   PubMed Web of Science ®Google Scholar
• Sharma SM, Choi D, Planck SR, et al. Insights in to the pathogenesis of axial spondyloarthropathy based on gene expression profiles. Arthritis Res Ther. 2009;11:R168. doi:10.1186/ar2855
   PubMed Web of Science ®Google Scholar
• van der Linden CJ, Breslau PJ, de Jong PC, Soeters PB, Timmermans F, Greep JM. Prospective study on the incidence of complications of right heart catheterization. Neth J Surg. 1984;36:127–129.
   PubMedGoogle Scholar
• Murphy-Ullrich JE, Sage EH. Revisiting the matricellular concept. Matrix Biol. 2014;37:1–14. doi:10.1016/j.matbio.2014.07.005
   PubMed Web of Science ®Google Scholar
• Brekken RA, Sage EH. SPARC, a matricellular protein: at the crossroads of cell-matrix. Matrix Biol. 2000;19:569–580. doi:10.1016/S0945-053X(00)00105-0
   PubMed Web of Science ®Google Scholar
• Rosset EM, Bradshaw AD. SPARC/osteonectin in mineralized tissue. Matrix Biol. 2016;52–54:78–87. doi:10.1016/j.matbio.2016.02.001
   PubMed Web of Science ®Google Scholar
• Socha MJ, Manhiani M, Said N, Imig JD, Motamed K. Secreted protein acidic and rich in cysteine deficiency ameliorates renal inflammation and fibrosis in angiotensin hypertension. Am J Pathol. 2007;171:1104–1112. doi:10.2353/ajpath.2007.061273
   PubMed Web of Science ®Google Scholar
• Motamed K, Blake DJ, Angello JC, et al. Fibroblast growth factor receptor-1 mediates the inhibition of endothelial cell proliferation and the promotion of skeletal myoblast differentiation by SPARC: a role for protein kinase A. J Cell Biochem. 2003;90:408–423. doi:10.1002/jcb.10645
   PubMed Web of Science ®Google Scholar
• Raines EW, Lane TF, Iruela-Arispe ML, Ross R, Sage EH. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci USA. 1992;89:1281–1285. doi:10.1073/pnas.89.4.1281
   PubMed Web of Science ®Google Scholar
• Arnold S, Mira E, Muneer S, et al. Forced expression of MMP9 rescues the loss of angiogenesis and abrogates metastasis of pancreatic tumors triggered by the absence of host SPARC. Exp Biol Med. 2008;233:860–873. doi:10.3181/0801-RM-12
   PubMed Web of Science ®Google Scholar
• Nie J, Sage EH. SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling. J Biol Chem. 2009;284:1279–1290. doi:10.1074/jbc.M808285200
   PubMed Web of Science ®Google Scholar
• Wang Q, Yang Q, Zhang A, Kang Z, Wang Y, Zhang Z. Silencing of SPARC represses heterotopic ossification via inhibition of the MAPK signaling pathway. Biosci Rep. 2019;2019:39.
   Google Scholar
• Nie J, Chang B, Traktuev DO, et al. IFATS collection: combinatorial peptides identify alpha5beta1 integrin as a receptor for the matricellular protein SPARC on adipose stromal cells. Stem Cells. 2008;26:2735–2745. doi:10.1634/stemcells.2008-0212
   PubMed Web of Science ®Google Scholar
• Tang MJ, Tai IT. A novel interaction between procaspase 8 and SPARC enhances apoptosis and potentiates chemotherapy sensitivity in colorectal cancers. J Biol Chem. 2007;282:34457–34467. doi:10.1074/jbc.M704459200
   PubMed Web of Science ®Google Scholar
• Jorgensen LH, Jepsen PL, Boysen A, et al. SPARC interacts with actin in skeletal muscle in vitro and in vivo. Am J Pathol. 2017;187:457–474. doi:10.1016/j.ajpath.2016.10.013
   PubMed Web of Science ®Google Scholar
• Omi S, Yamanouchi K, Nakamura K, Matsuwaki T, Nishihara M. Reduced fibrillar collagen accumulation in skeletal muscle of secreted protein acidic and rich in cysteine (SPARC)-null mice. J Vet Med Sci. 2019;81:1649–1654. doi:10.1292/jvms.19-0485
   PubMed Web of Science ®Google Scholar
• Delany AM, Hankenson KD. Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling. J Cell Commun Signal. 2009;3:227–238. doi:10.1007/s12079-009-0076-0
   PubMed Web of Science ®Google Scholar
• Delany AM, McMahon DJ, Powell JS, Greenberg DA, Kurland ES. Osteonectin/SPARC polymorphisms in Caucasian men with idiopathic osteoporosis. Osteoporos Int. 2008;19:969–978. doi:10.1007/s00198-007-0523-9
   PubMed Web of Science ®Google Scholar
• Boskey AL, Moore DJ, Amling M, Canalis E, Delany AM. Infrared analysis of the mineral and matrix in bones of osteonectin-null mice and their wildtype controls. J Bone Miner Res. 2003;18:1005–1011. doi:10.1359/jbmr.2003.18.6.1005
   PubMed Web of Science ®Google Scholar
• Zhu YS, Gu Y, Jiang C, Chen L. Osteonectin regulates the extracellular matrix mineralization of osteoblasts through P38 signaling pathway. J Cell Physiol. 2020;235:2220–2231. doi:10.1002/jcp.29131
   PubMed Web of Science ®Google Scholar
• Jundt G, Berghauser KH, Termine JD, Schulz A. Osteonectin--a differentiation marker of bone cells. Cell Tissue Res. 1987;248:409–415. doi:10.1007/BF00218209
   PubMed Web of Science ®Google Scholar
• Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol. 2007;7:292–304. doi:10.1038/nri2062
   PubMed Web of Science ®Google Scholar
• Nakamura S, Kamihagi K, Satakeda H, et al. Enhancement of SPARC (osteonectin) synthesis in arthritic cartilage. Increased levels in synovial fluids from patients with rheumatoid arthritis and regulation by growth factors and cytokines in chondrocyte cultures. Arthritis Rheum. 1996;39:539–551. doi:10.1002/art.1780390402
   PubMedGoogle Scholar
• Yang XL, Hu ZD, Wu Q, et al. Association of polymorphisms in SPARC and NLRP2 genes with rheumatoid arthritis in a Chinese Han population. Mod Rheumatol. 2015;25:67–71. doi:10.3109/14397595.2014.903595
   PubMed Web of Science ®Google Scholar
• Fueki H, Hino R, Yoshioka M, Nakamura M, Tokura Y. Calcinosis cutis associated with primary Sjogren’s syndrome: strong expression of osteonectin and matrix Gla protein. Rheumatology. 2011;50:2318–2320. doi:10.1093/rheumatology/ker304
   PubMed Web of Science ®Google Scholar
• Davies CA, Jeziorska M, Freemont AJ, Herrick AL. Expression of osteonectin and matrix Gla protein in scleroderma patients with and without calcinosis. Rheumatology. 2006;45(11):1349–1355. doi:10.1093/rheumatology/kei277
   PubMed Web of Science ®Google Scholar
• Zhou X, Tan FK, Reveille JD, et al. Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma. Arthritis Rheum. 2002;46:2990–2999. doi:10.1002/art.10601
   PubMed Web of Science ®Google Scholar
• Xu JR, Lin Y, Zhang CY, Li WM, Guo CJ, Ye L. Effects of comprehensive therapy on serum SPARC levels in ankylosing spondylitis patients accompanied with osteoporosis. Chin J Integrat Trad West Med. 2013;33:466–470.
   Google Scholar